64_CD SHAREHOLDER_NN INFORMATION_NN 7a_CD Substantial_NNP shareholdings_NNS The_DT shareholdings_NNS in_IN the_DT table_NN set_VBN out_RP below_IN represent_VBP the_DT shareholdings_NNS amounting_VBG to_TO 3_CD %_NN or_CC more_JJR of_IN the_DT ordinary_JJ share_NN capital_NN of_IN the_DT Company_NN that_WDT had_VBD been_VBN notified_VBN to_TO the_DT Company_NN in_IN accordance_NN with_IN Sections_NNS 198_CD to_TO 208_CD of_IN the_DT Companies_NNS Act_NNP 1985_CD ,_, at_IN the_DT time_NN of_IN publication_NN of_IN the_DT 2000_CD ,_, 2001_CD and_CC 2002_CD Annual_JJ Reports_NNS ._.
The_DT figures_NNS in_IN the_DT columns_NNS entitled_VBN 2001_CD Annual_JJ Report_NNP and_CC 2000_CD Annual_JJ Report_NNP do_VBP not_RB necessarily_RB represent_VB the_DT current_JJ shareholdings_NNS or_CC percentages_NNS held_VBN by_IN the_DT respective_JJ shareholders_NNS ._.
As_IN at_IN 11_CD March_NNP 2003_CD 2001_CD Annual_JJ Report_NNP 2000_CD Annual_JJ Report_NNP Number_NNP of_IN Number_NNP of_IN Number_NNP of_IN shares_NNS held_VBN Percentage_NN shares_NNS held_VBD Percentage_NN shares_NNS held_VBD Percentage_NN 1_CD Baxter_NNP International_NNP ,_, Inc._NNP 16,713,603_CD 16.87_CD %_NN 11,746,041_CD 12.62_CD %_NN 9,071,200_CD 10.23_CD %_NN Fidelity_NNP Management_NNP &_CC Research_NNP Company_NNP 6,010,194_CD 6.06_CD %_NN --_: -_: -_: Barclays_NNP PLC_NNP 4,950,803_CD 5.00_CD %_NN --_: -_: -_: Morley_NNP Fund_NNP Management_NNP Limited_NNP 4,022,012_CD 4.06_CD %_NN 3,650,893_CD 3.92_CD %_NN -_: -_: Legal_NNP &_CC General_NNP Investment_NNP Management_NNP Limited_NNP 3,067,3313.10_CD %_NN --_: -_: -_: Philips_NNP &_CC Drew_NNP Life_NNP Limited_NNP --_: -_: -_: 4,122,260_CD 4.65_CD %_NN Note_NN 1_CD In_IN December_NNP 2000_CD ,_, Acambis_NNP entered_VBD into_IN a_DT strategic_JJ alliance_NN with_IN Baxter_NNP ,_, as_IN a_DT result_NN of_IN which_WDT at_IN 11_CD March_NNP 2003_CD equity_NN subscriptions_NNS of_IN 19.9_CD m_NN net_NN of_IN expenses_NNS had_VBD been_VBN received_VBN ,_, representing_VBG 16.7_CD million_CD new_JJ ordinary_JJ shares_NNS as_IN shown_VBN above_IN ._.
The_DT remaining_VBG subscription_NN totalling_VBG 7.0_CD m_NN ,_, in_IN respect_NN of_IN a_DT further_JJ 4.6_CD million_CD new_JJ shares_NNS ,_, was_VBD received_VBN on_IN 27_CD March_NNP 2003_CD ,_, taking_VBG Baxters_NNP holding_VBG to_TO 21.3_CD million_CD new_JJ ordinary_JJ shares_NNS representing_VBG a_DT 20.6_CD %_NN holding_NN at_IN that_DT date_NN ._.
As_IN far_RB as_RB is_VBZ known_VBN to_TO the_DT Directors_NNS ,_, the_DT Company_NN is_VBZ not_RB directly_RB or_CC indirectly_RB owned_VBN or_CC controlled_VBN by_IN another_DT corporation_NN or_CC by_IN any_DT other_JJ government_NN and_CC the_DT only_JJ shareholder_NN directly_RB or_CC indirectly_RB owning_VBG more_JJR than_IN 10_CD %_NN of_IN the_DT Company_NN is_VBZ shown_VBN in_IN the_DT above_JJ table_NN ._.
All_DT shareholders_NNS have_VBP the_DT same_JJ voting_NN rights_NNS ._.
9a_CD Nature_NN of_IN trading_NN market_NN Comparative_JJ market_NN price_NN information_NN 9c_CD Acambis_NNP shares_NNS are_VBP traded_VBN on_IN the_DT London_NNP Stock_NNP Exchange_NNP under_IN the_DT symbol_NN ACM_NNP and_CC on_IN the_DT US_NNP Nasdaq_NNP National_NNP Market_NNP in_IN the_DT form_NN of_IN ADRs_NNPS under_IN the_DT symbol_NN ACAM_NNP ._.
The_DT number_NN of_IN outstanding_JJ ordinary_JJ shares_NNS of_IN 10p_JJ each_DT at_IN that_DT date_NN was_VBD 99,101,858_CD ._.
Comparative_JJ dividend_NN information_NN Acambis_NNP has_VBZ never_RB paid_VBN any_DT cash_NN dividends_NNS on_IN its_PRP$ shares_NNS and_CC does_VBZ not_RB anticipate_VB paying_VBG cash_NN dividends_NNS for_IN the_DT foreseeable_JJ future_NN ._.
65_CD 66_CD SHAREHOLDER_NN INFORMATION_NNP Annual_JJ General_NNP Meeting_VBG The_DT Annual_JJ General_NNP Meeting_VBG of_IN the_DT Company_NN will_MD be_VB held_VBN at_IN 10_CD a._NN m._NN on_IN 13_CD May_NNP 2003_CD at_IN the_DT offices_NNS of_IN Weil_NNP ,_, Gotshal_NNP &_CC Manges_NNP ,_, One_CD South_NNP Place_NNP ,_, London_NNP EC2M_NNP 2WG_NNP ._.
The_DT Notice_NNP of_IN the_DT Annual_JJ General_NNP Meeting_VBG accompanies_VBZ this_DT Annual_JJ Report_NNP and_CC Form_NN 20-F_NN ._.
Special_JJ business_NN The_DT special_JJ business_NN to_TO be_VB conducted_VBN at_IN the_DT Annual_JJ General_NNP Meeting_VBG AGM_NNP is_VBZ detailed_VBN in_IN the_DT Notice_NNP of_IN the_DT AGM_NNP ._.
In_IN addition_NN to_TO the_DT reappointment_NN of_IN LLP_NNP as_IN auditors_NNS as_IN discussed_VBN below_IN authority_NN is_VBZ being_VBG sought_VBN :_: to_TO change_VB certain_JJ rules_NNS within_IN the_DT Acambis_NNP share_NN option_NN and_CC share_NN incentive_NN plans_VBZ the_DT Share_NN Plans_NNS ._.
The_DT Directors_NNS will_MD seek_VB approval_NN to_TO amend_VB the_DT Share_NN Plans_NNS :_: a_DT to_TO provide_VB that_DT during_IN the_DT five_CD years_NNS following_VBG the_DT date_NN of_IN the_DT 2003_CD AGM_NNP the_DT number_NN of_IN shares_NNS which_WDT may_MD be_VB issued_VBN in_IN connection_NN with_IN share_NN options_NNS or_CC long-term_JJ incentive_NN awards_NNS may_MD not_RB exceed_VB 5_CD %_NN of_IN the_DT ordinary_JJ share_NN capital_NN of_IN the_DT Company_NN in_IN issue_NN from_IN time_NN to_TO time_NN ._.
This_DT will_MD replace_VB the_DT current_JJ dilution_NN limits_NNS applying_VBG under_IN the_DT Share_NN Plans_NNS :_: b_NN to_TO amend_VB the_DT Share_NN Plans_NNS so_IN that_IN the_DT Company_NN has_VBZ the_DT authority_NN to_TO update_VB these_DT plans_NNS during_IN the_DT five-year_JJ period_NN following_VBG the_DT date_NN of_IN the_DT AGM_NNP :_: and_CC c_NN such_JJ that_IN a_DT qualifying_VBG employee_NN or_CC Director_NNP may_MD ,_, in_IN any_DT financial_JJ year_NN ,_, be_VB granted_VBN discretionary_JJ share_NN options_NNS over_IN shares_NNS with_IN a_DT market_NN value_NN ,_, as_RB at_IN the_DT date_NN of_IN grant_NN ,_, of_IN up_RB to_TO two-times_NNS the_DT participants_NNS base_JJ annual_JJ salary_NN ._.
This_DT limit_NN could_MD be_VB extended_VBN if_IN the_DT participant_NN had_VBD been_VBN recruited_VBN ,_, in_IN which_WDT case_NN the_DT limit_NN shall_MD be_VB four-times_JJ his_PRP$ her_PRP$ base_NN annual_JJ salary_NN within_IN 12_CD months_NNS of_IN joining_VBG or_CC ,_, exceptionally_RB ,_, at_IN the_DT discretion_NN of_IN the_DT Remuneration_NNP Committee_NNP ,_, eighttimes_VBZ his_PRP$ her_PRP$ base_NN annual_JJ salary_NN if_IN the_DT participant_NN is_VBZ based_VBN in_IN the_DT US_NNP and_CC forfeits_NNS vested_VBN options_NNS with_IN an_DT immediate_JJ previous_JJ employer_NN by_IN reason_NN on_IN joining_VBG Acambis_NNP :_: to_TO introduce_VB a_DT new_JJ all-employee_JJ share_NN plan_NN for_IN US-based_JJ employees_NNS ._.
The_DT new_JJ plan_NN is_VBZ similar_JJ in_IN style_NN to_TO the_DT Acambis_NNP 1995_CD Savings-Related_NNP Share_NNP Option_NN Scheme_NN for_IN UK_NNP employees_NNS :_: to_TO give_VB the_DT Company_NN the_DT authority_NN to_TO purchase_VB up_RP to_TO 10_CD %_NN of_IN its_PRP$ own_JJ issued_VBN ordinary_JJ shares_NNS at_IN a_DT price_NN of_IN not_RB less_JJR than_IN 10_CD pence_NN per_IN share_NN and_CC not_RB more_JJR than_IN 5_CD %_NN above_IN the_DT average_NN of_IN the_DT middle_JJ market_NN quotations_NNS of_IN the_DT Companys_NNP shares_NNS as_IN shown_VBN in_IN the_DT London_NNP Stock_NNP Exchange_NNP Daily_NNP Official_NNP List_NN for_IN the_DT five_CD dealing_VBG days_NNS before_IN the_DT purchase_NN is_VBZ made_VBN ._.
This_DT authority_NN shall_MD expire_VB at_IN the_DT conclusion_NN of_IN the_DT Companys_NNPS next_IN AGM_NNP or_CC 15_CD months_NNS from_IN the_DT passing_NN of_IN this_DT resolution_NN ,_, whichever_WDT is_VBZ the_DT earlier_RBR :_: and_CC to_TO disapply_VB the_DT statutory_JJ pre-emption_NN rights_NNS in_IN respect_NN of_IN the_DT allotment_NN of_IN new_JJ shares_NNS pursuant_JJ to_TO rights_NNS issues_NNS or_CC otherwise_RB for_IN cash_NN up_RP to_TO an_DT aggregate_JJ nominal_JJ value_NN of_IN 518,691_CD ,_, being_VBG 5_CD %_NN of_IN the_DT currently_RB issues_NNS ordinary_JJ shares_NNS of_IN the_DT Company_NN in_IN accordance_NN with_IN the_DT current_JJ guidelines_NNS of_IN the_DT Investment_NNP Committee_NNP of_IN the_DT Association_NNP of_IN British_NNP Insurers_NNP and_CC the_DT National_NNP Association_NNP of_IN Pension_NNP Funds_NNPS ._.
This_DT authority_NN shall_MD expire_VB at_IN the_DT conclusion_NN of_IN the_DT Companys_NNPS next_IN AGM_NNP or_CC 15_CD months_NNS from_IN the_DT passing_NN of_IN this_DT resolution_NN ,_, whichever_WDT is_VBZ the_DT earlier_RBR ._.
Auditors_NNS Following_VBG the_DT conversion_NN of_IN our_PRP$ auditors_NNS to_TO a_DT limited_JJ liability_NN partnership_NN LLP_NNP from_IN 1_CD January_NNP 2003_CD ,_, resigned_VBD and_CC the_DT Directors_NNS appointed_VBN its_PRP$ successor_NN ,_, LLP_NNP ,_, as_IN auditors_NNS ._.
A_DT resolution_NN to_TO reappoint_VB LLP_NNP as_IN auditors_NNS to_TO the_DT Company_NN will_MD be_VB proposed_VBN at_IN the_DT AGM_NNP ._.
This_DT authority_NN shall_MD expire_VB at_IN the_DT conclusion_NN of_IN the_DT Companys_NNPS next_IN General_NNP Meeting_VBG ._.
were_VBD appointed_VBN as_IN auditors_NNS of_IN the_DT Company_NN in_IN March_NNP 2002_CD ,_, at_IN which_WDT time_NN the_DT current_JJ audit_NN partner_NN was_VBD also_RB appointed_VBN ._.
10b_JJ Memorandum_NNP and_CC Articles_NNPS of_IN Association_NNP A_NNP summary_NN of_IN the_DT principal_JJ provisions_NNS of_IN the_DT Groups_NNS Memorandum_NNP and_CC Articles_NNPS of_IN Association_NNP can_MD be_VB found_VBN by_IN referring_VBG to_TO the_DT Registration_NNP Statement_NNP on_IN Form_NN F-4_NN filed_VBN with_IN the_DT Securities_NNPS and_CC Exchange_NNP Commission_NNP in_IN April_NNP 1999_CD relating_VBG to_TO the_DT acquisition_NN of_IN Acambis_NNP Inc._NNP as_RB well_RB as_IN the_DT document_NN filed_VBN in_IN November_NNP 2000_CD in_IN relation_NN to_TO the_DT proposed_VBN subscription_NN by_IN Baxter_NNP ._.
A_DT copy_NN of_IN both_DT the_DT Memorandum_NNP and_CC Articles_NNPS of_IN Association_NNP of_IN the_DT Company_NN has_VBZ been_VBN filed_VBN with_IN the_DT Registrar_NNP of_IN Companies_NNS ._.
The_DT Memorandum_NNP contains_VBZ the_DT fundamental_JJ provisions_NNS of_IN the_DT Companys_NNP constitution_NN ._.
The_DT Articles_NNPS contain_VBP the_DT rules_NNS for_IN the_DT internal_JJ management_NN and_CC control_NN of_IN the_DT Company_NN ._.
10h_JJ Documents_NNS on_IN display_NN Certain_NNP documents_NNS referred_VBD to_TO in_IN this_DT Annual_JJ Report_NNP and_CC Form_NN 20-F_NN are_VBP available_JJ for_IN inspection_NN at_IN the_DT registered_JJ office_NN of_IN the_DT Company_NN ._.
COMPANY_NNP INFORMATION_NNPS AND_CC ADVISERS_NNPS Company_NNP Secretary_NNP ,_, registered_VBD Announcements_NNP Registrars_NNP office_NN and_CC Group_NNP headquarters_NNS First_JJ quarter_NN results_NNS May_MD Capita_NNP Registrars_NNPS Elizabeth_NNP Brown_NNP Second_NNP quarter_NN interim_JJ results_NNS September_NNP The_DT Registry_NNP Peterhouse_NNP Technology_NNP Park_NNP Third_NNP quarter_NN results_NNS November_NNP 34_CD Beckenham_NNP Road_NNP 100_CD Fulbourn_NNP Road_NNP Final_JJ results_NNS March_NNP Beckenham_NNP Cambridge_NNP CB1_NNP 9PT_NNP Kent_NNP BR3_NNP 4TU_NNP UK_NNP Corporate_NNP advisers_NNS UK_NNP Tel_NNP :_: 44_CD 0_CD 1223 275 300_CD Financial_NNP advisers_NNS and_CC stockbrokers_NNS Auditors_NNS 4a_VBP Registered_NNP number_NN :_: 2863682_CD Deutsche_NNP Bank_NNP LLP_NNP Date_NNP of_IN incorporation_NN :_: 19_CD October_NNP 1993_CD Winchester_NNP House_NNP Abacus_NNP House_NNP Country_NN of_IN jurisdiction_NN :_: England_NNP and_CC Wales_NNP 1_CD Great_NNP Winchester_NNP Street_NNP Castle_NNP Park_NNP London_NNP EC2N_NNP 2DB_NNP Cambridge_NNP CB3_NNP 0AN_NNP US_NNP operations_NNS UK_NNP UK_NNP 38_CD Sidney_NNP Street_NNP Cambridge_NNP Legal_NNP advisers_NNS Massachusetts_NNP 02139_CD Weil_NNP ,_, Gotshal_NNP &_CC Manges_NNP USA_NNP One_CD South_NNP Place_NNP Tel_NNP :_: 1_CD 617 761 4200_CD London_NNP EC2M_NNP 2WG_NNP UK_NNP Shareholder_NN information_NN The_DT share_NN price_NN is_VBZ obtainable_JJ in_IN most_JJS UK_NNP and_CC US_NNP Patent_NNP Agents_NNPS national_JJ newspapers_NNS and_CC on_IN Acambis_NNP website_NN at_IN Reddie_NNP &_CC Grose_NNP www_NN ._.
com_NN Daedalus_NNP House_NNP Station_NNP Road_NNP London_NNP Stock_NNP Exchange_NNP mnemonic_JJ ACM_NNP Cambridge_NNP CB1_NNP 2RE_NNP US_NNP Nasdaq_NNP National_NNP Market_NNP ticker_NN symbol_NN ACAM_NNP UK_NNP Reuters_NNP reference_NN ACM_NNP ._.
L_NNP Clark_NNP &_CC Elbing_NNP LLP_NNP 176_CD Federal_NNP Street_NNP Analyst_NNP coverage_NN of_IN Acambis_NNP Boston_NNP Altium_NNP Capital_NNP Massachusetts_NNP 02110_CD Cazenove_NNP USA_NNP C._NNP E._NNP Unterberg_NNP ,_, Towbin_NNP Commerzbank_NNP Bankers_NNP Credit_NNP Suisse_NNP First_NNP Boston_NNP Barclays_NNP Bank_NNP PLC_NNP Deutsche_NNP Bank_NNP Corporate_NNP Banking_NNP Evolution_NNP Beeson_NNP Gregory_NNP PO_NNP Box_NNP 885_CD Goldman_NNP Sachs_NNP Mortlock_NNP House_NNP ING_NNP Barings_NNPS Vision_NNP Park_NNP KBC_NNP Peel_NNP Hunt_NNP Histon_NNP Merrill_NNP Lynch_NNP Cambridge_NNP CB4_NNP 9DE_NNP Nomura_NNP UK_NNP Teather_NNP &_CC Greenwood_NNP UBS_NNP Warburg_NNP WestLB_NNP Panmure_NNP Williams_NNP fide_VBD Bro_NNP 67_CD 68_CD INDEX_NNP Accounting_NNP policies_NNS 22-24_JJ Goodwill_NNP 23_CD ,_, 27_CD Senior_JJ management_NN 11_CD Administrative_JJ costs_NNS 25_CD Group_NNP Executive_NNP Committee_NNP 53_CD Share_NN capital_NN 33-34_CD ADR_NNP pricing_NN 65_CD Government_NNP grants_NNS 23_CD Share_NN options_NNS 24_CD ,_, 33-34_CD ,_, 59-61_CD Annual_JJ General_NNP Meeting_VBG 66_CD Share_NN pricing_NN 65_CD Arilvax_NNP 8_CD ,_, 13_CD Health_NNP and_CC safety_NN 51_CD Share_NN register_NN analysis_NN 64_CD Audit_NNP Committee_NNP 52_CD H._NNP pylori_NN 9_CD ,_, 13_CD Shareholder_NN information_NN 64-66_CD Auditors_NNS 16-17_CD ,_, 66_CD HolaVax-ETEC_NN 9_CD ,_, 13_CD Shareholders_NNS funds_NNS 35_CD Aventis_NNP Pasteur_NNP 29-30_CD ,_, 45_CD HolaVax-Typhoid_JJ 9_CD ,_, 13_CD Smallpox_NNP 2-3_CD ,_, 6-8_CD ,_, 12-13_CD Staff_NN costs_NNS 26_CD Balance_NN sheets_NNS 19_CD ,_, 20_CD Independent_NNP auditors_NNS report_VBP 16-17_CD Statement_NNP of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS 18_CD Baxter_NNP 7_CD ,_, 12_CD ,_, 45_CD Interest_NN 25_CD Stock_NNP 23_CD ,_, 30_CD Berna_NNP Biotech_NNP 13_CD Internal_NNP controls_NNS 53_CD Stock_NNP options_NNS see_VBP Share_NN options_NNS Board_NNP of_IN Directors_NNS 10-11_CD ,_, 49_CD ,_, 50_CD ,_, 52_CD Investments_NNPS 23_CD ,_, 28-30_CD Strategy_NNP 6-9_CD Subsidiaries_NNPS 28_CD Capital_NN expenditure_NN 15_CD Japanese_JJ encephalitis_NNS Substantial_JJ shareholdings_NNS 64_CD Cash_NN 15_CD see_VBP ChimeriVax-JE_NNP Summarised_NNP Group_NNP statements_NNS 48-49_CD Cash_NN flow_NN 21_CD ,_, 40-41_CD Joint_NNP venture_NN 23_CD ,_, 29-30_CD ,_, 45_CD CDC_NNP 44-45_CD Taxation_NNP 15_CD ,_, 23_CD ,_, 26_CD ,_, 46_CD Chairmans_NNPS statement_NN 1_CD Leases_VBZ 24_CD ,_, 31_CD ,_, 33_CD Trade_NNP investments_NNS 29_CD Charitable_JJ donations_NNS 51_CD Trading_NN results_NNS 14-15_CD ChimeriVax-Dengue_NNP 13_CD Manufacturing_NNP 4-5_CD ,_, 14-15_CD Travel_NN vaccines_NNS 8-9_CD ChimeriVax-JE_NNP 8-9_CD ,_, 13_CD MD&A_NNP 42-47_CD ChimeriVax-West_NNP Nile_NNP 9_CD ,_, 13_CD Memorandum_NN and_CC Articles_NNPS of_IN Association_NNP 66_CD US_NNP GAAP_NNP reconciliation_NN 37-42_CD C._NNP difficile_NN 9_CD ,_, 13_CD MVA_NNP 3_CD ,_, 7_CD ,_, 8_CD ,_, 12-13_CD Clinical_JJ operations_NNS 4_CD VIG_NNP 3_CD ,_, 8_CD ,_, 12_CD Collaboration_NNP agreements_NNS 44-46_CD Nominations_NNPS Committee_NNP 53_CD Company_NN information_NN and_CC advisers_NNS 67_CD Notes_NNS to_TO Group_NNP financial_JJ statements_NNS 22-42_JJ West_NNP Nile_NNP virus_NN 9_CD ,_, 13_CD Corporate_JJ governance_NN statement_NN 52-55_CD Corporate_NNP social_JJ responsibility_NN 11_CD ,_, 51_CD Operating_NN review_NN 12-13_CD Cost_NN of_IN sales_NNS 14_CD ,_, 22_CD Organisational_NNP structure_NN 28_CD Abbreviations_NNS used_VBN in_IN this_DT document_NN Creditors_NNS 31_CD Product_NN update_VBP 12-13_CD ADR_NNP American_NNP Depositary_NNP Receipt_NNP Debtors_NNP 30_CD Profit_NN and_CC loss_NN account_NN 18_CD APB_NNP Accounting_NNP Principles_NNP Board_NNP Directors_NNS interests_NNS 51_CD ,_, 59_CD Pensions_NNS 23_CD ,_, 37_CD ,_, 57_CD ,_, 58_CD BIA_NNP BioIndustry_NNP Association_NNP Directors_NNS remuneration_VBP 26_CD ,_, 58_CD Political_JJ donations_NNS 51_CD CDC_NNP US_NNP Centers_NNPS for_IN Disease_NNP Control_NNP and_CC Directors_NNS report_VBP 51_CD Post_NNP balance_NN sheet_NN events_NNS 37_CD Prevention_NNP Directors_NNS responsibilities_NNS 16_CD Property_NN 47_CD EITF_NNP Emerging_VBG Issues_NNS Task_NNP Force_NNP Discontinued_NNP operations_NNS 25_CD FASB_NNP Financial_NNP Accounting_NNP Standards_NNP Board_NNP Dividends_NNPS 51_CD R&D_NN 3_CD ,_, 12-13_CD FDA_NNP US_NNP Food_NNP and_CC Drug_NNP Administration_NNP Reconciliation_NNP to_TO US_NNP GAAP_NNP 37-42_CD FIN_NNP FASB_NNP Interpretation_NNP Number_NNP Earnings_NNS per_IN share_NN 27_CD Registrars_NNPS 67_CD FRS_NNP Financial_NNP Reporting_NNP Standard_NNP Employees_NNP 15_CD ,_, 26_CD ,_, 51_CD Related_VBN party_NN transactions_NNS 37_CD R&DR_NN esearch_NN and_CC development_NN Environment_NNP 51_CD Remuneration_NNP Committee_NNP 52_CD ,_, 56_CD SEC_NNP US_NNP Securities_NNPS and_CC Exchange_NNP Commission_NNP Evans_NNP Vaccines_NNP Limited_NNP 46_CD Remuneration_NNP report_NN 56-63_CD SFAS_NNP Statement_NN of_IN Financial_NNP Accounting_NNP Exchange_NNP rate_NN information_NN 47_CD Reserves_NNS 35_CD Standard_NNP Risk_NNP factors_NNS 54-55_CD UITF_NNP Urgent_NNP Issues_NNP Task_NNP Force_NNP Financial_NNP commitments_NNS 36-37_CD UK_NNP GAAP_NNP United_NNP Kingdom_NNP generally_RB accepted_VBD Financial_NNP instruments_NNS 31-33_CD Financial_NNP review_NN 14-15_CD Sales_NNS and_CC marketing_NN 5_CD accounting_NN principles_NNS Fixed_VBN asset_NN investments_NNS 23_CD ,_, 28_CD ,_, 30_CD Segmental_JJ information_NN 24_CD US_NNP GAAP_NNP United_NNP States_NNPS generally_RB accepted_VBN Foreign_NNP currencies_NNS 24_CD ,_, 32_CD ,_, 47_CD Selected_VBN financial_JJ information_NN 48-49_CD accounting_NN principles_NNS CROSS-REFERENCE_NNP TO_TO FORM_NNP 20-F_NNP This_DT cross-reference_NN to_TO Form_NN 20-F_NN is_VBZ provided_VBN to_TO assist_VB those_DT who_WP are_VBP more_RBR familiar_JJ with_IN the_DT contents_NNS and_CC layout_NN of_IN an_DT Annual_JJ Report_NNP on_IN Form_NN 20-F_NN ._.
1a_CD We_PRP have_VBP denoted_VBN this_DT Form_NN 20-F_JJ information_NN by_IN using_VBG this_DT symbol_NN ,_, where_WRB the_DT number_NN denotes_VBZ the_DT specific_JJ item_NN on_IN the_DT cross-reference_NN ._.
The_DT information_NN in_IN this_DT document_NN that_WDT is_VBZ referred_VBN to_TO in_IN the_DT following_VBG table_NN shall_MD be_VB deemed_VBN to_TO be_VB filed_VBN with_IN the_DT Securities_NNPS and_CC Exchange_NNP Commission_NNP for_IN all_DT purposes_NNS ._.
Item_NN Page_NNP Item_NNP Page_NNP Item_NNP Page_NNP 1_CD Identity_NN of_IN directors_NNS ,_, senior_JJ management_NN and_CC advisers_NNS n_VBP a_DT 7_CD Major_JJ shareholders_NNS and_CC related_VBN party_NN transactions_NNS 12_CD Description_NN of_IN securities_NNS other_JJ than_IN equity_NN securities_NNS n_VBP a_DT a_DT Major_JJ shareholders_NNS 64_CD 2Offer_JJ statistics_NNS and_CC expected_VBN timetable_NN n_NN a_DT b_NN Related_VBN party_NN transactions_NNS 37_CD 13_CD Defaults_NNS ,_, dividend_NN arrears_NNS and_CC delinquencies_NNS none_NN c_NN Interests_NNS of_IN experts_NNS and_CC counsel_NN n_VBP a_DT 3Key_NNP Information_NNP 14_CD Material_NNP modifications_NNS to_TO the_DT rights_NNS of_IN security_NN holders_NNS n_VBP a_DT a_DT Selected_VBN financial_JJ data_NNS 48-49_CD 8_CD Financial_NNP information_NN see_VBP Item_NNP 17_CD and_CC use_NN of_IN proceeds_NNS b_NN Capitalisation_NNP and_CC indebtedness_NN n_VBP a_DT c_NN Reasons_NNS for_IN the_DT offer_NN and_CC use_NN of_IN proceeds_NNS n_VBP a_DT 9The_JJ offer_NN and_CC listing_NN 15_CD Controls_NNP and_CC procedures_NNS 53_CD d_SYM Risk_NNP factors_NNS 54-55_CD a_DT The_DT offer_NN and_CC listing_NN details_NNS 65_CD b_NN Plan_NN of_IN distribution_NN n_VBP a_DT 16_CD Reserved_VBN item_NN n_NN a_DT 4Information_NN on_IN the_DT Company_NN c_NN Markets_NNS 65_CD a_DT History_NN and_CC development_NN of_IN the_DT Company_NN 1-15_CD ,_, 67_CD d_SYM Selling_VBG shareholders_NNS n_VBP a_DT 17_CD Financial_NNP statements_NNS b_NN Business_NN overview_VBD 1-15_CD ,_, 24_CD ,_, 43-44_CD ,_, 54-55_CD e_SYM Dilution_NNP n_VBD a_DT a_DT Directors_NNS responsibilities_NNS 16_CD c_NN Organisational_NNP structure_NN note_NN 14_CD a_DT 28_CD f_SYM Expenses_NNS of_IN the_DT issue_NN n_VBD a_DT b_NN Independent_NNP auditors_NNS report_VBP to_TO members_NNS of_IN Acambis_NNP plc_NN 16-17_CD d_SYM Property_NN ,_, plants_NNS and_CC equipment_NN 47_CD c_NN Group_NNP profit_NN and_CC loss_NN account_NN 18_CD 10_CD Additional_JJ information_NN d_SYM Group_NNP statement_NN of_IN total_JJ recognized_VBN gains_NNS and_CC losses_NNS 18_CD 5_CD Operating_NN and_CC financial_JJ review_NN and_CC prospects_NNS a_DT Share_NN capital_NN n_VBD a_DT e_SYM Group_NNP balance_NN sheet_NN 19_CD a_DT Operating_NN results_NNS 14-15_CD ,_, 43_CD b_NN Memorandum_NNP and_CC Articles_NNPS of_IN Association_NNP 66_CD f_SYM Company_NN balance_NN sheet_NN 20_CD b_NN Liquidity_NN and_CC capital_NN resources_NNS 44_CD c_NN Material_NNP contracts_NNS 44-46_CD g_NNP Group_NNP cash_NN flow_NN statement_NN 21_CD c_NN Research_NN and_CC development_NN ,_, patents_NNS and_CC licences_NNS etc._FW ._.
14_CD ,_, 43_CD ,_, 44-46_CD d_SYM Exchange_NNP controls_VBZ 47_CD h_NN Notes_NNS to_TO Group_NNP financial_JJ statements_NNS 22-49_JJ d_SYM Trend_NNP information_NN 14-15_CD ,_, 43_CD e_SYM Taxation_NNP 46_CD f_SYM Dividends_NNPS and_CC paying_VBG agents_NNS n_VBP a_DT 18_CD Financial_NNP statements_NNS see_VBP Item_NNP 17_CD 6_CD Directors_NNS ,_, senior_JJ management_NN and_CC employees_NNS g_VBP Statement_NN by_IN experts_NNS n_VBP a_DT a_DT Directors_NNS and_CC senior_JJ management_NN 50-51_CD h_VBP Documents_NNS on_IN display_NN 66_CD 19_CD Exhibits_NNS n_VBP a_DT b_NN Compensation_NNP 56-63_CD i_FW Subsidiary_NNP information_NN n_VBD a_DT c_NN Board_NNP practices_NNS 52-53_JJ d_SYM Employees_NNS note_VBP 8_CD 26_CD 11_CD Quantitative_JJ and_CC qualitative_JJ disclosure_NN about_IN market_NN risk_NN e_SYM Share_NN ownership_NN 59-62_CD Financial_NNP instruments_NNS 31-33_CD 69_CD Acambis_NNP plc_NN Peterhouse_NNP Technology_NNP Park_NNP 100_CD Fulbourn_NNP Road_NNP Cambridge_NNP CB1_NNP 9PT_NNP UK_NNP Tel_NNP :_: 44_CD 0_CD 1223 275 300_CD Fax_NNP :_: 44_CD 0_CD 1223 416 300_CD E-mail_NN :_: acambis@acambis_NNS ._.
